Speaker: Jeffrey Langland. Part 1 describes the use of Fritillaria thunbergii as an adjuvant therapy in vaccination (variolation) against smallpox in ancient Chinese medicine, and the comparison with modern vaccine equivalents of microbial attenuation and the use of immunological adjuvants. Part 2 describes in vitro and in vivo testing of astragalus extract, which defines its role in priming a potential immune response as well as its effect on blood flow and wound healing. Part 3 addresses the question of whether Echinacea purpurea is actually an effective cold and flu remedy. Results suggest that different portions of the echinacea plant may have varying effects on both the immune and antiviral response.
- Event: 2017 Southwest Conference on Botanical Medicine
- Product Code: 17SW32
- Availability: In Stock